Update publication information. Gypenosides is a traditional drug for the treatment of metabolic disorders. Recent studies have confirmed its anti-nonalcoholic fatty liver disease (NAFLD) effects, but the underlying mechanisms are still not fully understood. The purpose of this study was to explore the protective mechanism of gypenosides against NAFLD in mice and provide new insights for the prevention and treatment of NAFLD.